Active Ingredient History
Yellow fever vaccine is a vaccine that protects against yellow fever. Yellow fever is a viral infection that occurs in Africa and South America. Most people begin to develop immunity within ten days of vaccination and 99% are protected within one month, and this appears to be lifelong. The vaccine can be used to control outbreaks of disease. It is given either by injection into a muscle or just under the skin. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Yellow Fever (approved 1935)
Communicable Diseases (Phase 2)
Dengue (Phase 3)
Dermatitis, Atopic (Phase 1/Phase 2)
Encephalitis, Japanese (Phase 2)
Healthy Volunteers (Phase 4)
HIV Infections (Phase 4)
Immunity (Phase 4)
Immunization (Phase 1/Phase 2)
Malaria (Phase 3)
Malaria, Falciparum (Early Phase 1)
Malaria Vaccines (Phase 3)
Rotavirus Infections (Phase 4)
Severe Dengue (Phase 2)
Streptococcal Infections (Phase 2)
Vaccines (Phase 4)
Viremia (Phase 1)
Virus Diseases (Phase 2)
Yellow Fever (Phase 4)
Yellow Fever Vaccine (Phase 4)
Zika Virus Infection (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue